Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,202
Closed -$771K 2547
2026
Q1
$771K Buy
10,202
+1,500
+17% +$113K 0.01% 343
2025
Q4
$648K Sell
8,702
-258
-3% -$18.9K 0.01% 397
2025
Q3
$605K Buy
8,960
+638
+8% +$42.4K 0.01% 432
2025
Q2
$542K Buy
8,322
+685
+9% +$41.1K 0.01% 418
2025
Q1
$472K Buy
7,637
+1,616
+27% +$107K 0.01% 426
2024
Q4
$434K Sell
6,021
-1,097
-15% -$85.7K 0.01% 412
2024
Q3
$528K Buy
7,118
+1,923
+37% +$154K 0.01% 445
2024
Q2
$405K Buy
5,195
+1,452
+39% +$109K 0.01% 454
2024
Q1
$292K Buy
3,743
+205
+6% +$15.3K ﹤0.01% 402
2023
Q4
$245K Buy
3,538
+790
+29% +$55K ﹤0.01% 388
2023
Q3
$222K Buy
2,748
+2,152
+361% +$163K ﹤0.01% 410
2023
Q2
$48K Sell
596
-5,690
-91% -$465K ﹤0.01% 708
2023
Q1
$470K Buy
6,286
+1,675
+36% +$135K 0.01% 308
2022
Q4
$298K Buy
4,611
+2,322
+101% +$165K 0.01% 351
2022
Q3
$158K Buy
2,289
+528
+30% +$36.6K ﹤0.01% 388
2022
Q2
$135K Buy
+1,761
New +$131K ﹤0.01% 410

Other funds holding HOLX

Blue Trust Inc's HOLX Position: Q2 2026 in Review

Blue Trust Inc sold out of Hologic (HOLX) in Q2 2026, closing a stake of 10,202 shares — an estimated $771K sold.

Blue Trust Inc first reported a position in HOLX in Q2 2022 and held it in 16 quarters. The position peaked at $771K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Blue Trust Inc reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Blue Trust Inc sold 10,202 Hologic shares in Q2 2026, an estimated $771K.
  • Blue Trust Inc first reported a position in Hologic in Q2 2022 and held it in 16 quarters.
  • Blue Trust Inc's Hologic position peaked at $771K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.